Cynthia Miller‐Stein
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)United States Military Academy(US)
Publications by Year
Research Areas
Analytical Chemistry and Chromatography, Migraine and Headache Studies, Blood Coagulation and Thrombosis Mechanisms, Neuropeptides and Animal Physiology, Antibiotics Pharmacokinetics and Efficacy
Most-Cited Works
- → Mechanistic investigation of ionization suppression in electrospray ionization(2000)1,064 cited
- → Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of N -[(3 R ,6 S )-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1 H -imidazo[4,5- b ]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974)(2007)146 cited
- → Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 Pyridines(2003)120 cited
- → Discovery and Evaluation of Potent P1 Aryl Heterocycle-Based Thrombin Inhibitors(2004)93 cited
- → Description and validation of a staggered parallel high performance liquid chromatography system for good laboratory practice level quantitative analysis by liquid chromatography/tandem mass spectrometry(2001)64 cited
- → Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion Channel